logo
AAT Bioquest

ATTO 647 PEG4 DBCO

Product key features

  • Ex/Em: 646/666 nm
  • Extinction coefficient: 120,000 cm-1M-1
  • Reactive group: DBCO
  • Copper-Free Bioorthogonal Labeling: Enables efficient azide conjugation via SPAAC without copper, ideal for sensitive systems
  • Robust Quantum Yield & Stability: Maintains bright fluorescence with high photo and thermal stability
  • Zwitterionic: Minimizes non-specific binding to biological surfaces, reducing background noise in live-cell imaging and super-resolution microscopy
  • Hydrophilic PEG4 Spacer: Enhances solubility and minimizes steric hindrance for enhanced biocompatibility

Product description

ATTO 647 is a rhodamine-derived fluorescent dye optimized for applications within the red spectral region, offering spectral characteristics similar to Cy5. Its characterized by a high molar absorptivity, robust fluorescence quantum yield, high photostability, and good aqueous solubility, making it well-suited for demanding experimental conditions. The dye is highly hydrophilic, with an excitation maximum between the 615-660 nm range, making it compatible with the 633 nm He:Ne laser, 647 nm Krypton-Ion laser, and 650 nm diode laser. As a zwitterionic molecule, ATTO 647 carries a net neutral charge. The dye is stable under physiological pH conditions and in buffers with a pH of up to 8, though it gradually degrades at higher pH levels. ATTO 647 is ideal for advanced applications in single-molecule detection and high-resolution microscopy techniques, including PALM, dSTORM, and STED microscopy. It is also compatible with flow cytometry (FACS), fluorescence in situ hybridization (FISH), FRET, and various other biological assays.

The DBCO derivative of ATTO 647 is a highly reactive cycloalkyne optimized for copper-free click chemistry (SPAAC, strain-promoted azide-alkyne cycloaddition). This derivative exhibits a significantly higher reaction rate with azides compared to other cyclooctynes and copper-catalyzed click reactions (CuAAC). Uniquely, DBCO does not react with tetrazines, allowing for its use in bioorthogonal reactions alongside trans-cyclooctenes and tetrazines. For applications where the presence of copper is problematic, ATTO 647 DBCO serves as an effective alternative to copper-dependent fluorescent alkynes.

Spectrum

Page updated on April 25, 2025

Ordering information

Price
Unit size
Catalog Number2832
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Physical properties

Solvent

DMSO

Spectral properties

Correction Factor (260 nm)

0.08

Correction Factor (280 nm)

0.04

Extinction coefficient (cm -1 M -1)

120000

Excitation (nm)

646

Emission (nm)

666

Quantum yield

0.20

Storage, safety and handling

Certificate of OriginDownload PDF
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Storage

Freeze (< -15 °C); Minimize light exposure
Schematic illustrating the strain‐promoted azide–alkyne cycloaddition (SPAAC) between a dibenzocyclooctyne (DBCO)–dye conjugate and an azide‐modified biomolecule. The DBCO’s ring strain drives the copper‐free reaction with the azide to form a stable 1,2,3-triazole linkage, avoiding potential toxicity of copper catalysts. This bioorthogonal labeling strategy proceeds efficiently under mild conditions, making it especially valuable for live‐cell imaging, in vivo studies, and other sensitive bioconjugation applications.
Schematic illustrating the strain‐promoted azide–alkyne cycloaddition (SPAAC) between a dibenzocyclooctyne (DBCO)–dye conjugate and an azide‐modified biomolecule. The DBCO’s ring strain drives the copper‐free reaction with the azide to form a stable 1,2,3-triazole linkage, avoiding potential toxicity of copper catalysts. This bioorthogonal labeling strategy proceeds efficiently under mild conditions, making it especially valuable for live‐cell imaging, in vivo studies, and other sensitive bioconjugation applications.
Schematic illustrating the strain‐promoted azide–alkyne cycloaddition (SPAAC) between a dibenzocyclooctyne (DBCO)–dye conjugate and an azide‐modified biomolecule. The DBCO’s ring strain drives the copper‐free reaction with the azide to form a stable 1,2,3-triazole linkage, avoiding potential toxicity of copper catalysts. This bioorthogonal labeling strategy proceeds efficiently under mild conditions, making it especially valuable for live‐cell imaging, in vivo studies, and other sensitive bioconjugation applications.